Medical Research News

RSS

Patient-specific stem cell lines - now a real possibility

Immune rejection problems could affect any one of us. This unique research shows that producing individual patient cell lines for our own future needs is now something we might all want to consider.

28 Nov 2005

Chemical found in plants helps prevent lung cancer

According to the results of an animal study, it is suggested that treatment with a chemical found in various plants, may help prevent lung cancer caused by cigarette smoking.

28 Nov 2005

Cranberry flavoured toothpaste may help stop decay

According to researchers cranberries, well-known for their ability to help thwart urinary tract infections, may also help prevent tooth decay and cavities.

28 Nov 2005

Zinc supplements shown to be good for children with HIV

According to new research zinc supplements are a safe and effective way to reduce illness in children with HIV.

28 Nov 2005

People with mild symptoms of depression pay more attention to their social environment

Surprisingly, people with mild depression are actually more tuned into the feelings of others than those who aren't depressed, a team of Queen's psychologists has discovered.

28 Nov 2005

Smoking cessation in cancer patients

A new report says despite a growing body of evidence that continued smoking after a cancer diagnosis has substantial adverse effects on treatment effectiveness, overall survival, risk of other cancers, and quality of life, up to one-half of cancer patients who smoke continue to do so or relapse after trying to quit.

28 Nov 2005

MRI to detect magnetic probes of tiny iron oxide particles successfully tracks implanted cells in cancer patients

By using MRI to detect magnetic probes of tiny iron oxide particles, an international research team for the first time has successfully tracked immune-stimulating cells implanted into cancer patients for treatment purposes.

28 Nov 2005

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

Duke University researchers have now shown that selectively killing the population of regulatory T cells in cancer patients - cells that normally function to restrain the activity of the immune response - improves the ability of a cancer vaccine to stimulate tumor-specific T cells.

28 Nov 2005

Spear Therapeutics raise $8.5 Million to fund cancer drug development

Cancer Research Technology (CRT), Bloomsbury Bioseed Fund (BBSF), De Montfort University (DMU) and the Gray Cancer Institute announce today that U.S. venture capital firm Advent International has invested $8.5 million in Spear Therapeutics Ltd.

28 Nov 2005

GRK5's role in restenosis

Researchers at Jefferson Medical College have begun to clarify the role of a protein - and potential drug target - in the process by which arteries re-clog after treatment.

28 Nov 2005

GRK2 protein - potential drug target for heart failure

A protein that plays an important regulatory role in heart failure in the heart also exerts powerful effects on the adrenal gland, Jefferson Medical College researchers have found. The protein, GRK2, is a potential drug target for heart failure.

28 Nov 2005

Fullerenes can help fend off damage to normal tissue from radiation

Using transparent zebrafish embryos, researchers at Jefferson Medical College have shown that a microscopic nanoparticle can help fend off damage to normal tissue from radiation.

28 Nov 2005

Coaxing human embryonic stem cells to make dopamine

For all of the promise embryonic stem cells hold for therapies for neurodegenerative diseases such as Parkinson's disease, they are notoriously difficult to use.

28 Nov 2005

Darbepoietin alpha may provide cardiac protection 24 hours after heart attack

A drug has been shown to provide some protection to the heart from injury even if given as much as 24 hours after a heart attack, Jefferson Medical College researchers report.

28 Nov 2005

Potential new treatment for pancreatic cancer

Johns Hopkins Kimmel Cancer Center researchers are encouraged by early results of a treatment vaccine for pancreatic cancer, a disease with few options and low odds for long-term survival.

28 Nov 2005

African-Americans fare better in the short term following coronary interventions

Racial disparities in cardiovascular outcomes are well-established, however new findings from University of Pittsburgh researchers indicate that African-Americans fare better in the short term following coronary interventions.

26 Nov 2005

Methylphenidate may be effective in treating autism

Methylphenidate, a medication used to treat attention-deficit hyperactivity disorder (ADHD), may be effective in treating hyperactivity symptoms in children with autism and related pervasive developmental disorders, researchers report in the November Archives of General Psychiatry.

26 Nov 2005

Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia

Women who have had pre-cancerous cells removed remain at higher than average risk of developing cervical cancer in the 20 years following treatment, says research in the British Medical Journal (BMJ).

26 Nov 2005

Zinc supplements safe for chidren with HIV

Zinc-deficient children living in communities where they do not receive adequate amounts of zinc from their diet should be given supplements, even if they are HIV-infected, according to researchers from the Johns Hopkins Bloomberg School of Public Health and other institutions.

26 Nov 2005

Researchers gain detailed view yet of the heart of the translocon

Researchers have gained the most detailed view yet of the heart of the translocon, a channel through which newly constructed proteins are inserted into the cell membrane. The process of transporting proteins across or into membranes is a critical function that occurs in every cell.

26 Nov 2005